Featured Research

from universities, journals, and other organizations

Research breakthrough for drugs via the skin: Outermost layer of skin described in detail

Date:
April 26, 2012
Source:
Karolinska Institutet
Summary:
Scientists have succeeded in describing the structure and function of the outermost layer of the skin – the stratum corneum – at a molecular level. This opens the way not only for the large-scale delivery of drugs via the skin, but also for a deeper understanding of skin diseases.

A research team at Karolinska Institutet in Sweden has succeeded in describing the structure and function of the outermost layer of the skin -- the stratum corneum -- at a molecular level. This opens the way not only for the large-scale delivery of drugs via the skin, but also for a deeper understanding of skin diseases.

"You could say that we've solved the puzzle of the skin barrier, something that has great potential significance for dermatology," says principal investigator Lars Norlén, associate professor at Karolinska Institutet's Dermatology and Venereology Unit.

The upper layer of the skin is a watertight barrier called the stratum corneum. A research group at Karolinska Institutet have now structure determined this barrier layer at a molecular level, unlocking the secrets of the skin's perviousness. This will hopefully enable the widespread administration of drugs though the skin instead of via pills or injections, which brings several advantages; for example, it means that drugs can be delivered evenly over time instead of in doses, and patients bypass the first-passage metabolism, whereby the entire dose passes the liver, thus increasing the risk of adverse effects.

"We can now construct computer simulations to help us find out which substances have to be added to different drugs to open up the skin," says Dr Norlén. "We hope to one day be able to administer regular drugs like insulin and antibiotics this way."

To conduct their study, the researchers developed an entirely new experimental approach involving rapidly freezing tiny skin samples and studying them under a low-temperature electron microscope.

"This has given us an unprecedented opportunity to determine the molecular structure and function of native cells and tissues in situ without having our data muddied by the addition of dyes, solvents or plastics," adds Dr Norlén.

Their discovery has profound significance for dermatology. The majority of skin diseases manifest themselves in some kind of functional disorder of the skin's protective barrier, and the researchers now want to use their method to determine such changes at a molecular level. If they succeed in this, it will be a decisive step towards a deeper understanding of these diseases and, hopefully, the development of new, improved treatments.

"This may be a breakthrough for dermatology," says Dr Norlén. "Our team has devoted the past 20 years to unlocking the mysteries of the stratum corneum."

All land-living organisms are surrounded by a protective watertight shell. In humans and other vertebrates, it comprises a uniquely complex layer of fat between the cells of the stratum corneum.

"Understanding how this protective barrier has developed is an important step towards explaining why life on land exists and is even possible," says Dr Lars Norlén.


Story Source:

The above story is based on materials provided by Karolinska Institutet. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ichiro Iwai, HongMei Han, Lianne den Hollander, Stina Svensson, Lars-Göran Öfverstedt, Jamshed Anwar, Jonathan Brewer, Maria Bloksgaard, Aurelie Laloeuf, Daniel Nosek, Sergej Masich, Luis A Bagatolli, Ulf Skoglund, Lars Norlén. The Human Skin Barrier Is Organized as Stacked Bilayers of Fully Extended Ceramides with Cholesterol Molecules Associated with the Ceramide Sphingoid Moiety. Journal of Investigative Dermatology, 2012; DOI: 10.1038/jid.2012.43

Cite This Page:

Karolinska Institutet. "Research breakthrough for drugs via the skin: Outermost layer of skin described in detail." ScienceDaily. ScienceDaily, 26 April 2012. <www.sciencedaily.com/releases/2012/04/120426104946.htm>.
Karolinska Institutet. (2012, April 26). Research breakthrough for drugs via the skin: Outermost layer of skin described in detail. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/04/120426104946.htm
Karolinska Institutet. "Research breakthrough for drugs via the skin: Outermost layer of skin described in detail." ScienceDaily. www.sciencedaily.com/releases/2012/04/120426104946.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins